Advanced Search

Technical Analysis for CSTL - Castle Biosciences, Inc.

Grade Last Price % Change Price Change
D 60.66 -6.59% -4.28
CSTL closed down 6.59 percent on Tuesday, April 20, 2021, on 73 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical CSTL trend table...
Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Multiple of Ten Bullish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Hammer Candlestick Bullish -6.59%
Lizard Bullish Bullish Day Trade Setup -6.59%
Doji - Bullish? Reversal -6.59%
Down 3 Days in a Row Weakness -6.59%
Down 4 Days in a Row Weakness -6.59%
Older End-of-Day Signals for CSTL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR about 14 hours ago
Down 5% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Down 3% about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Melanoma Medical Tests Gene Expression Metastasis Dsw

Is CSTL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 16 Castle Biosciences Presents Data at the 10th World Congress of Melanoma and 17th European Association of Dermato-Oncology Congress
Apr 15 Late-Breaking New Independent Validation Study of 1,674 Patients Demonstrates Castle Biosciences' i31-GEP Artificial Intelligence Algorithm Improves Precision of Sentinel Lymph Node Positivity Prediction in Cutaneous Melanoma
Apr 14 Largest, Independent, Prospective Study Demonstrates Utility of DecisionDx®-Melanoma for Prediction of Outcomes in Patients With Cutaneous Melanoma Referred for Sentinel Node Biopsy
Apr 13 Castle Biosciences Announces Prospective, Multi-Center Publication Demonstrating DecisionDx®-Melanoma as Significant, Independent Predictor of Patient Outcomes in Cutaneous Melanoma
Apr 1 Castle Biosciences Collaborates with the Melanoma Research Foundation for "Ask the Expert" Live Webinar Series with Melanoma Experts
Mar 31 Illumina upgraded at Canaccord Genuity with readthrough to other firms on FTC challenge
Mar 29 Castle Biosciences to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 25 Castle Biosciences Announces Publication Demonstrating Dermatologists Are Increasingly Integrating DecisionDx-Melanoma Into Melanoma Clinical Management Decisions
Mar 11 Castle Biosciences, Inc. (CSTL) Moves 5.3% Higher: Will This Strength Last?
Mar 9 Castle Biosciences, Inc. 2020 Q4 - Results - Earnings Call Presentation
See more CSTL news...

Indicators

Indicator Value
52 Week High 107.69
52 Week Low 26.13
Average Volume 316,599
200-Day Moving Average 58.58
50-Day Moving Average 73.07
20-Day Moving Average 66.60
10-Day Moving Average 67.47
Average True Range 4.35
ADX 16.24
+DI 19.12
-DI 32.84
Chandelier Exit (Long, 3 ATRs ) 62.88
Chandelier Exit (Short, 3 ATRs ) 69.79
Upper Bollinger Band 75.43
Lower Bollinger Band 57.77
Percent B (%b) 0.16
BandWidth 26.52
MACD Line -1.31
MACD Signal Line -0.98
MACD Histogram -0.3338
Fundamentals Value
Market Cap 1.21 Billion
Num Shares 19.9 Million
EPS -3.14
Price-to-Earnings (P/E) Ratio -19.32
Price-to-Sales 14.28
Price-to-Book 5.95
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 69.14
Resistance 3 (R3) 69.50 67.04 67.72
Resistance 2 (R2) 67.04 64.88 66.86 67.25
Resistance 1 (R1) 63.85 63.55 62.62 63.49 66.78
Pivot Point 61.39 61.39 60.78 61.21 61.39
Support 1 (S1) 58.20 59.23 56.97 57.84 54.54
Support 2 (S2) 55.74 57.90 55.56 54.07
Support 3 (S3) 52.55 55.74 53.60
Support 4 (S4) 52.19